Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ONDS vs GSK✓SelectedUSD · GSKONDS vs GSK performance historyLatest closeAs of-8.72%11/16
Stock and ETF performance explorer

ONDS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-56.4%
GSK return
+46.9%
Excess return
-103.3%
Maximum drawdown
-96.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.7%-0.1%-8.6%-8.7%
7D-21.1%-1.3%-19.8%-21.2%
30D-22.0%+2.7%-24.8%-21.8%
3M-49.0%+2.7%-51.7%-48.8%
6M-55.6%+3.3%-59.0%-55.5%
YTD-51.7%+6.5%-58.2%-51.6%
1Y-34.4%+10.7%-45.1%-34.3%
3Y+500.0%+64.4%+435.6%+474.3%
5Y-56.4%+46.7%-103.1%-67.3%
All-56.4%+46.9%-103.3%-67.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling